Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study

BACKGROUND: Upacicalcet is a novel small-molecule calcimimetic agent developed for intravenous injection. Here, we evaluated the long-term efficacy and safety of upacicalcet treatment via intraindividual dose adjustment in haemodialysis patients with secondary hyperparathyroidism (SHPT). METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Inaguma, Daijo, Koiwa, Fumihiko, Tokumoto, Masanori, Fukagawa, Masafumi, Yoneda, Shinji, Yasuzawa, Hisami, Asano, Kenji, Hagita, Keiko, Inagaki, Yosuke, Honda, Daisuke, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689153/
https://www.ncbi.nlm.nih.gov/pubmed/38045997
http://dx.doi.org/10.1093/ckj/sfad213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689153/
https://www.ncbi.nlm.nih.gov/pubmed/38045997
http://dx.doi.org/10.1093/ckj/sfad213

Ejemplares similares